ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0953

Increased Risk of Preterm Delivery Phenotypes and Hypertensive Disorders of Pregnancy in First Deliveries of Patients with Systemic Vasculitis

Audra Horomanski1, Gary Shaw2, Jonathan Mayo3 and Julia Simard4, 1Stanford University, Stanford, CA, 2Stanford University School of Medicine, Palo Alto, 3Stanford University, Stanford, 4Stanford University School of Medicine, Palo Alto, CA

Meeting: ACR Convergence 2022

Keywords: pregnancy, Vasculitis

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 13, 2022

Title: Reproductive Issues in Rheumatic Disorders Poster

Session Type: Poster Session B

Session Time: 9:00AM-10:30AM

Background/Purpose: Systemic vasculitides are rare disorders characterized by vascular inflammation that can affect virtually every organ system. Recent treatment advances have increased life expectancy and reduced reproductive toxicity, allowing more patients the opportunity to pursue pregnancy. Little is known about maternal and fetal risks associated with pregnancy and delivery in these patients, although small studies suggest a higher risk of hypertensive disorders of pregnancy. Given the rarity of systemic vasculitides, analysis of large datasets offers the greatest opportunity for drawing meaningful conclusions.

Methods: Deliveries to nulliparous patients with prevalent systemic vasculitides (Takayasu’s Arteritis (TAK), Behçet’s Disease (BD), ANCA-Associated Vasculitis (AAV), and Kawasaki Disease (KD)) were identified using ICD-9 codes in maternally linked data and birth records from the California Office of State Health Planning and Development (OSHPD) and California Vital Statistics from 1991 to 2012. Maternal hypertensive disorders of pregnancy, including preeclampsia and gestational hypertension, and preterm delivery (PTD) phenotypes of all PTD (20-36 weeks), preterm premature rupture of membranes (PPROM) and spontaneous PTD were identified. Multivariable Poisson regression models estimated risk ratios (RRs) of these outcomes compared to the general obstetric population without history of rheumatic disease. Models were adjusted for maternal age, race/ethnicity, education level, prenatal care, payer, and delivery year.

Results: 87 first deliveries to patients with systemic vasculitis were identified (TAK: 14; AAV: 31; BD: 26; KD: 6) and compared to 4,191,909 deliveries of the general population. Adjusted RR for all PTD was elevated in vasculitis patients (RR 3.22, 95% CI 2.12, 4.89) as were the RRs of all PTD phenotypes including PPROM (RR 3.96, 95% CI 1.78-8.81) and spontaneous PTD (RR 5.10, 95% CI 3.02, 8.62). Of the spontaneous PTDs, 16.7% were early preterm deliveries (20-31 weeks), with the remaining 83.3% occurring between 32-36 weeks. Vasculitis patients also had an elevated risk of hypertensive disorders of pregnancy (RR 2.99, 95% CI 1.70, 5.27).

Conclusion: Among first deliveries, we found that patients with systemic vasculitis have an elevated risk of preterm delivery phenotypes as well as maternal hypertensive disorders of pregnancy.


Disclosures: A. Horomanski, Chemocentryx; G. Shaw, None; J. Mayo, None; J. Simard, None.

To cite this abstract in AMA style:

Horomanski A, Shaw G, Mayo J, Simard J. Increased Risk of Preterm Delivery Phenotypes and Hypertensive Disorders of Pregnancy in First Deliveries of Patients with Systemic Vasculitis [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/increased-risk-of-preterm-delivery-phenotypes-and-hypertensive-disorders-of-pregnancy-in-first-deliveries-of-patients-with-systemic-vasculitis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/increased-risk-of-preterm-delivery-phenotypes-and-hypertensive-disorders-of-pregnancy-in-first-deliveries-of-patients-with-systemic-vasculitis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology